Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Acute Myeloid Leukemia
100%
Aptamer
100%
Nucleic Acid Aptamer
100%
Targeted Therapy
100%
Aptamer-drug Conjugates (ApDCs)
100%
Acute Myeloid Leukemia Cells
71%
CD117
57%
Methotrexate
57%
Leukemia Therapy
42%
Chemical Synthesis
28%
Cell Growth
14%
Cancer Cells
14%
High Affinity
14%
Therapeutic Proteins
14%
Cell Lysate
14%
Marrow
14%
Cell Apoptosis
14%
Clinical Value
14%
Chemotherapy Regimen
14%
Cell Cycle Arrest
14%
Functional Assay
14%
DNA Aptamer
14%
Chemically Modified
14%
No Toxicity
14%
Marrow Cells
14%
Single-stranded DNA (ssDNA)
14%
Drug Use
14%
Growth Inhibition
14%
G1 Phase
14%
Selective Growth
14%
Personalized Medicine
14%
G-quadruplex Structure
14%
Functional Molecules
14%
Sequence Alignment
14%
Treatment Conditions
14%
Methotrexate Conjugate
14%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Targeted Therapy
100%
Oligonucleotide
100%
Drug Conjugate
100%
Aptamer
100%
Methotrexate
45%
Leukemia Cell
45%
Biological Marker
18%
Cancer Cell
9%
Cell Growth
9%
Programmed Cell Death
9%
Chemotherapy
9%
Cell Cycle Checkpoint
9%
Cell Cycle Arrest
9%
Conjugate
9%
G1 Phase
9%
Growth Inhibition
9%
Single Stranded DNA
9%
Personalized Medicine
9%
Sequence Alignment
9%
Guanine Quadruplex
9%
Side Effect
9%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Oligonucleotide
100%
Aptamer
100%
Drug Conjugate
100%
Methotrexate
45%
Biological Marker
18%
Malignant Neoplasm
9%
Chemotherapy
9%
Single Stranded DNA
9%
Guanine Quadruplex
9%
Side Effect
9%
Immunology and Microbiology
Myeloid
100%
Conjugate
100%
Methotrexate
55%
Leukemia Cell
55%
CD117
44%
Cancer Cell
11%
Cell Growth
11%
DNA Strand
11%
Programmed Cell Death
11%
Cell Cycle Arrest
11%
Cell Cycle Checkpoint
11%
Cell Lysate
11%
Growth Inhibition
11%
Cell Cycle G1 Phase
11%
Sequence Alignment
11%
Material Science
Chemical Synthesis
100%
Cell Growth
50%